PHP
GRTX

Parkman Healthcare Partners’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Parkman Healthcare Partners’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-540,847
Closed -$1.69M – 113
2023
Q2 		$1.69M Buy
540,847
+15,847
+3% +$47.1K 0.29% 80
2023
Q1 		$1.34M Buy
+525,000
New +$1.08M 0.29% 69

Other funds holding GRTX

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Parkman Healthcare Partners's GRTX Position: Q3 2023 in Review

Parkman Healthcare Partners sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q3 2023, closing a stake of 540,847 shares — an estimated $1.69M sold.

Parkman Healthcare Partners first reported a position in GRTX in Q1 2023 and held it in 2 quarters. The position peaked at $1.69M in Q2 2023. 38 funds tracked by Wall St. Rank hold GRTX as of Q3 2023.

  • Parkman Healthcare Partners reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Parkman Healthcare Partners sold 540,847 Galera Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.69M.
  • Parkman Healthcare Partners first reported a position in Galera Therapeutics, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
  • Parkman Healthcare Partners's Galera Therapeutics, Inc. Common Stock position peaked at $1.69M in Q2 2023.
  • 38 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Parkman Healthcare Partners's 13F filing for Q3 2023, filed 14 Nov 2023.